Protective effect of resveratrol on acute endotoxemia-induced nephrotoxicity in rat through nitric oxide independent mechanism

Free Radical Research

Volumn 42, Issue 11-12, 2008, Pages 913-920

  Sebai, Hichem ^a,b   Ben Attia, Mossadok ^a   Sani, Mamane ^a   Aouani, Ezzedine ^a   Ghanem Boughanmi, Néziha ^a  

^a University of Carthage   (Tunisia)

^b University of the Mediterranean Aix Marseille II   (France)

Author keywords

Iron; Kidney; Lipopolysaccharide; Nitric oxide; Oxidative stress; Resveratrol

Indexed keywords

CATALASE; IRON; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PEROXIDASE; RESVERATROL; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME ACTIVITY; HEMODYNAMIC PARAMETERS; HISTOPATHOLOGY; IRON KINETICS; IRON TRANSPORT; KIDNEY FUNCTION; LIPID PEROXIDATION; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RAT; RENAL PROTECTION;

ANIMALS; ENDOTOXEMIA; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; LIPID PEROXIDATION; LIPOPOLYSACCHARIDES; MALE; NITRIC OXIDE; RATS; RATS, WISTAR; STILBENES; SUPEROXIDE DISMUTASE;

NEGIBACTERIA; RATTUS;

EID: 57649159450     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760802555577     Document Type: Article

References (49)

1. Freudenberg, MA and Galanos, C. (1990) Bacterial lipopolysaccharides: structure, metabolism and mechanisms of action. Int Rev Immunol, 6, pp. 207-221.
2. Westphal, M., Stubbe, H., Bone, HG, Daudel, F., Vocke, S., Van Aken, H. and Booke, M. (2002) Hemodynamic effects of exogenous adrenomedullin in healthy and endotoxemic sheep. Biochem Biophys Res Commun, 296, pp. 134-138.
3. Taniguchi, T., Kanakura, H., Takemoto, Y., Kidani, Y. and Yamamoto, K. (2003) Effects of ketamine and propofol on the ratio of interleukin-6 to interleukin-10 during endotoxemia in rats. Tohoku J Exp Med, 200, pp. 85-92.
4. Finkel, T. and Holbrook, NJ. (2000) Oxidants, oxidative stress and the biology of ageing. Nature, 408, pp. 239-247.
5. Randerath, K., Randerath, E., Smith, CV and Chang, J. (1996) Structural origins of bulky oxidative DNA adducts (type II I-compounds) as deduced by oxidation of oligonucleotides of known sequence. Chem Res Toxicol, 9, pp. 247-254.
6. Mallis, RJ, Buss, JE and Thomas, JA. (2001) Oxidative modification of H-ras: S-thiolation and S-nitrosylation of reactive cysteines. Biochem J, 355, pp. 145-153.
7. Morel, L., Lescoat, G., Cillard, J., Pasdeloup, N., Brissot, P. and Cillard, P. (1990) Kinetic evaluation of free malondialdehyde and enzyme leakage as indices of iron damage in rat hepatocyte cultures. Involvement of free radicals. Biochem Pharmacol, 39, pp. 1647-1655.
8. Sugino, K., Dhi, K., Yamada, K. and Kawasaki, T. (1987) The role of lipid peroxidation in endotoxin-induced hepatic damage and the protective effect of antioxidants. Surgery, 101, pp. 746-752.
9. Soleas, GJ, Diamandis, EP and Goldberg, DM. (1997) Resveratrol: A molecule whose time has come? And gone?. Clin Biochem, 30, pp. 91-113.
10. Das, S., Fraga, CG and Das, DK. (2006) Cardioprotective effect of resveratrol via HO-1 expression involves p38 map kinase and PI-3-kinase signaling, but does not involve NFkappaB. Free Radic Res, 40, pp. 1066-1075.
11. Bastianetto, S., Zheng, WH and Quirion, R. (2000) Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons. Br J Pharmacol, 131, pp. 711-720.
12. Giovannini, L., Migliori, M., Longoni, BM, Das, DK, Bertelli, AA, Panichi, V., Filippi, C. and Bertelli, A. (2001) Resveratrol, a polyphenol found in wine, reduces ischemia reperfusion injury in rat kidneys. J Cardiovasc Pharmacol, 37, pp. 262-270.
13. Chander, V., Tirkey, N. and Chopra, K. (2005) Resveratrol, a polyphenolic phytoalexin protects against cyclosporine-induced nephrotoxicity through nitric oxide dependent mechanism. Toxicology, 210, pp. 55-64.
14. Draper, HH and Hadley, M. (1990) Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol, 186, pp. 421-431.
15. Misra, HP and Fridovich, I. (1972) The role of superoxide anion in autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem, 247, pp. 3170-3175.
16. Aebi, H. (1984) Catalase in vitro. Methods Enzymol, 105, pp. 121-126.
17. Chance, B. and Maehly, AC. (1955) Assay of catalases and peroxidases. Methods Enzymol, 2, pp. 764-817.
18. Green, LC, Wagner, DA, Glogowski, J., Shipper, PL, Wishnok, JS and Tannenbaum, SR. (1982) Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem, 126, pp. 131-138.
19. Leardi, A., Caraglia, M., Selleri, C., Pepe, S., Pizzi, C., Notaro, R., Fabbrocini, A., De Lorenzo, S., Musico, M., Abbruzzese, A., Bianco, AR and Tagliaferri, P. (1998) Desferioxamine increases iron depletion and apoptosis induced by ara-C of human myeloid leukaemic cells. Br J Haematol, 102, pp. 746-752.
20. Hartree, EF. (1972) Determination of protein: A modification of the Lowry method that gives a linear photometric response. Anal Biochem, 48, pp. 422-427.
21. Kanter, M., Coskun, O., Armutcu, F., Uz, YH and Kizilay, G. (2005) Protective effects of vitamin C, alone or in combination with vitamin A, on endotoxin-induced oxidative renal tissue damage in rats. Tohoku J Exp Med, 206, pp. 155-162.
22. Morales, AI, Buitrago, JM, Santiago, JM, Fernandez-Tagarro, M., Lopez-Novoa, JM and Perez-Barriocanal, F. (2002) Protective effect of trans-resveratrol on gentamicin-induced nephrotoxicity. Antioxidants Redox Signal, 4, pp. 893-898.
23. Morales, AI, Rodriguez-Barbero, A., Vicente-Sanchez, C., Mayoral, P., Lopez-Novoa, JM and Perez-Barriocanal, F. (2006) Resveratrol inhibits gentamicin-induced mesangial cell contraction. Life Sci, 78, pp. 2373-2377.
24. Silan, C., Uzun, O., Comunoǧlu, NU, Gokcen, S., Bedirhan, S. and Cengiz, M. (2007) Gentamicin-induced nephrotoxicity in rats ameliorated and healing effects of resveratrol. Biol Pharm Bull, 30, pp. 79-83.
25. Do Amaral, CL, Francescato, HD, Coimbra, TM, Costa, RS, Darin, JD, Antunes, LM and Bianchi Mde, L. (2008) Resveratrol attenuates cisplatin-induced nephrotoxicity in rats. Arch Toxicol, 82, pp. 363-370.
26. de Jesus Soares, T, Volpini, RA, Francescato, HD, Costa, RS, da Silva, CG and Coimbra, TM. (2007) Effects of resveratrol on glycerol-induced renal injury. Life Sci, 81, pp. 647-656.
27. Cadenas, S. and Barja, G. (1999) Resveratrol, melatonin, vitamin E, and PBN protect against renal oxidative DNA damage induced by the kidney carcinogen KBrO3. Free Radic Biol Med, 26, pp. 1531-1537.
28. Saito, M., Satoh, S., Kojima, N., Tada, H., Sato, M., Suzuki, T., Senoo, H. and Habuchi, T. (2005) Effects of a phenolic compound, resveratrol, on the renal function and costimulatory adhesion molecule CD86 expression in rat kidneys with ischemia/reperfusion injury. Arch Histol Cytol, 68, pp. 41-49.
29. Sener, G., Tuǧtepe, H., Yuksel, M., Cetinel, S., Gedik, N. and Yeǧen, BC. (2006) Resveratrol improves ischemia/ reperfusion-induced oxidative renal injury in rats. Arch Med Res, 37, pp. 822-829.
30. Tadolini, B., Juliano, C., Piu, L., Franconi, F. and Cabrini, L. (2000) Resveratrol inhibition of lipid peroxidation. Free Radic Res, 33, pp. 105-114.
31. Ray, PS, Maulik, G., Cordis, GA, Bertelli, AAE, Bertelli, A. and Das, DK. (1999) The red wine antioxidant resveratrol protects isolated rat hearts from ischemia-reperfusion injury. Free Radic Biol Med, 27, pp. 160-169.
32. Mokni, M., Elkahoui, S., Limam, F., Amri, M. and Aouani, E. (2007) Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat. Neurochem Res, 32, pp. 981-987.
33. Kheir-Eldin, AA, Motawi, TK, Gad, MZ and Abd-ElGawad, HM. (2001) Protective effect of vitamin E, beta-carotene and N-acetylcysteine from the brain oxidative stress induced in rats by lipopolysaccharide. Int J Biochem Cell Biol, 33, pp. 475-482.
34. Yang, J., Mori, K., Li, JY and Barasch, J. (2003) Iron, lipocalin, and kidney epithelia. Am J Physiol Renal Physiol, 285, pp. 9-18.
35. Collins, HL. (2003) The role of iron in infections with intracellular bacteria. Immunol Lett, 85, pp. 193-195.
36. Bullen, JJ, Rogers, HJ, Spalding, PB and Ward, CG. (2005) Iron and infection: The heart of the matter. FEMS Immunol Med Microbiol, 43, pp. 325-330.
37. Peyssonnaux, C., Zinkernagel, AS, Datta, V., Lauth, X., Johnson, RS and Nizet, V. (2006) TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood, 107, pp. 3727-3732.
38. Mackenzie, EL, Iwasaki, K. and Tsuji, Y. (2008) Intracellular iron transport and storage: From molecular mechanisms to health implications. Antioxidants Redox Signal, 10, pp. 997-1030.
39. Devireddy, LR, Gazin, C., Zhu, X. and Green, MR. (2005) A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell, 123, pp. 1293-1305.
40. Sunil, VR, Patel, KJ, Nilsen-Hamilton, M., Heck, DE, Laskin, JD and Laskin, DL. (2007) Acute endotoxemia is associated with upregulation of lipocalin 24p3/Lcn2 in lung and liver. Exp Mol Pathol, 83, pp. 177-187.
41. Ding, WQ, Liu, B., Vaught, JL, Yamauchi, H. and Lind, SE. (2005) Anticancer activity of the antibiotic clioquinol. Cancer Res, 65, pp. 3389-3395.
42. Boult, J., Roberts, K., Brookes, MJ, Hughes, S., Bury, JP, Cross, SS, Anderson, GJ, Spychal, R., Iqbal, T. and Tselepis, C. (2008) Overexpression of cellular iron import proteins is associated with malignant progression of esophageal adenocarcinoma. Clin Cancer Res, 14, pp. 379-387.
43. Kitajima, S., Tsuda, M., Eshita, N., Matsushima, Y., Saitoh, M., Momma, J. and Kurokawa, Y. (1995) Lipopolysaccharide-associated elevation of serum and urinary nitrite/nitrate levels and hematological changes in rats. Toxicol Lett, 78, pp. 135-140.
44. Bi, XL, Yang, JY, Dong, YS, Wang, JM, Cui, YH, Ikeshima, T., Zhao, YQ and Wu, CF. (2005) Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia. Int Immunopharmacol, 5, pp. 185-193.
45. Mokni, M., Limam, F., Elkahoui, S., Amri, M. and Aouani, E. (2007) Strong cardioprotective effect of resveratrol, a red wine polyphenol, on isolated rat hearts after ischemia/reperfusion injury. Arch Biochem Biophys, 457, pp. 1-6.
46. Hobbs, AJ, Higgs, A. and Moncada, S. (1999) Inhibition of nitric oxide synthase as a potential therapeutic target. Annu Rev Pharmacol Toxicol, 39, pp. 191-220.
47. Tunctan, B., Uludag, O., Altug, S. and Abacioglu, N. (1998) Effect of nitric oxide synthase inhibition in lipopolysaccharide-induced sepsis in mice. Pharmacol Res, 38, pp. 405-411.
48. Juan, ME, Vinardell, MP and Planas, JM. (2002) The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J Nutr, 132, pp. 257-260.
49. Chance, B. and Maehly, AC. (1955) Assay of catalases and peroxidases. Methods Enzymol, 2, pp. 764-817.